
DASA-58
CAS No. 1203494-49-8
DASA-58 ( —— )
产品货号. M17188 CAS No. 1203494-49-8
DASA-58 是一种特异性、有效的丙酮酸激酶 M2 (PKM2) 激活剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥300 | 有现货 |
![]() ![]() |
5MG | ¥518 | 有现货 |
![]() ![]() |
10MG | ¥786 | 有现货 |
![]() ![]() |
25MG | ¥1604 | 有现货 |
![]() ![]() |
50MG | ¥2795 | 有现货 |
![]() ![]() |
100MG | ¥4431 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称DASA-58
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述DASA-58 是一种特异性、有效的丙酮酸激酶 M2 (PKM2) 激活剂。
-
产品描述DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.
-
体外实验DASA-58 (15 μM; 2 h) potentiates the antitumor effects of other metabolic stressors.?DASA-58 (15 μM; 24 h, 72 h) enhances pyruvate kinase activity in breast cancer cells without a clear effect on proliferation.?DASA-58 (30 μM, 60 μM; 0-72 h) enhances extracellular acidification and lactate levels in BCa cell lines and induce extracellular acidification levels in prostate cancer cell lines.DASA-58 (15 μM, 30 μM; 0-72 h) affects respiration levels in BCa cells without an indication of mitochondrial damage.DASA-58 (15 μM; 0-72 h) not rescues TXNIP levels in any combintion and mitochondrial inhibitors enhance PKM2 effects on activating AMPK signaling (T172 phosphorylation of AMPK) .DASA-58 (15 μM; 0-72 h) leads to depletion in TXNIP levels independent of AMPK and ER signaling, and not through enhanced proteasomal degradation but rather depleted upstream glycolytic intermediates. Cell Viability Assay Cell Line:Five breast cancer cell lines (BCa cells) (MDA MB 231, MDA MB 468, HCC 1443, T47-D, MCF7, LnCap, PC3, and DU145)Concentration:15 μM Incubation Time:2 h Result:Could be exploited by other metabolic stressors.Western Blot Analysis Cell Line:BCa cells Concentration:15 μM Incubation Time:24 h, 72 h Result:Showed comparable PKM2 protein levels in five breast cancer cell lines, except HCC1443 cells and MDA MB 468 that showed the highest and lowest PKM2 protein levels, respectively.
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点CDK
-
受体PKM2
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1203494-49-8
-
分子量453.53
-
分子式C19H23N3O6S2
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 35 mg/mL 77.17 mM
-
SMILESc1(cc(ccc1)S(=O)(=O)N1CCN(CCC1)S(=O)(=O)c1cc2OCCOc2cc1)N
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Palsson-McDermott EM, et al. Cell Metab. 2015, 21(1), 65-80.
产品手册




关联产品
-
CDK inhibitor E9
CDK抑制剂E9是一种新型CDK抑制剂,可以克服ABC介导的THZ1耐药性,作为CDK9的有效非共价抑制剂和CDK12的共价抑制剂。
-
Ro-3306
Ro-3306 是一种有效的选择性 CDK1 抑制剂,对 CDK1、CDK1/cyclin B1 和 CDK2/cyclin E 的 Ki 值分别为 20 nM、35 nM 和 340 nM。
-
Ryuvidine
Ryuvidine 是一种有效的选择性 CDK4 抑制剂,IC50 为 6.0 uM,选择性是 CDK2 的 30 倍以上 (IC50>100 uM)。